Open Access

Enhanced oxygen transfer rate and bioprocess yield by using magnetite nanoparticles in fermentation media of erythromycin

  • Ghazal Labbeiki1,
  • Hossein Attar1Email author,
  • Amir Heydarinasab1,
  • Sayed Sorkhabadi2, 3 and
  • Alimorad Rashidi4
DARU Journal of Pharmaceutical Sciences201422:66

DOI: 10.1186/s40199-014-0066-5

Received: 10 August 2014

Accepted: 7 September 2014

Published: 16 September 2014

Abstract

Background

Magnetite nanoparticles have widespread biomedical applications. In the aerobic bioprocesses, oxygen is a limiting factor for the microbial metabolic rate; hence a high availability of oxygen in the medium is crucial for high fermentation productivity. This study aimed to examine the effect of using magnetite nanoparticles on oxygen transfer rate in erythromycin fermentation culture.

Methods

Magnetite nanoparticles were synthetized through co-precipitation method. After observing the enhanced oxygen transfer rate in deionized water enriched with magnetite nanoparticles, these nanoparticles were used in the media of by Saccharopolyspora erythraea growth to explore their impact on erythromycin fermentation titer. Treatments comprised different concentrations of magnetite nanoparticles, (0, 0.005, 0.02 v/v).

Results

In the medium containing 0.02 v/v magnetite nanoparticles, KLa was determined to be 1.89 time higher than that in magnetite nanoparticle-free broth. An improved 2.25 time higher erythromycin titer was obtained in presence of 0.02 v/v nanoparticles.

Conclusions

Our results, demonstrate the potential of magnetite nanoparticles for enhancing the productivity of aerobic pharmaceutical bioprocesses.

Keywords

Bioprocess Oxygen transfer rate Mass transfer coefficient (KLa) Magnetite nanoparticles Pharmaceutical biotechnology Fermentation Erythromycin Saccharopolyspora erythraea

Background

Oxygen is one of the most important substrate influencing productivity of aerobic bioprocesses [1]. While oxygen has a low solubility in most fermentation media, the uptake of the major amount of oxygen by microorganisms during the fermentation decreases the dissolved oxygen level in liquid to less than the critical concentration, rendering oxygen the limiting factor for productivity. A significantly low rate of oxygen transfer from gas into liquid, will lead to a decreased microbial metabolic rate, thereby low fermentation performance. Therefore an adequate supply of O2 is required for achieving a high fermentation productivity, particularly in high-cell density bioprocesses [2] such as erythromycin fermentation by Saccharopolyspora erythraea.

The Oxygen Transfer Rate (OTR) is usually determined by volumetric mass transfer coefficient (KLa). This variable is affected by several factors, including composition of medium, and geometrical and operating characteristic of the bioreactor [3]. Several methods have been proposed for improving KLa, including use of more effective agitation and aeration systems, enriching air with pure oxygen, reducing gas bubbles' size and enhancing gas hold up [2], and modifying physical properties of the medium by adding dispersed phases containing particles in size of μm [4] capable of solubilizing O2 more than water.

Recent studies have shown that nanomaterials have potential to positively influence the variables affecting biochemical processes. For instance, Olle et al. [4] showed that O2 mass transfer improves in the presence of colloidal nanoparticle dispersion. In addition, Nagi et al. [5] reported an enhanced oxygen mass transfer rate in the presence of nano-size particles.

Following this growing line of research, in the present study, first aqueous solution of magnetite nanoparticles (MNPs) was prepared. The solution was then added to the fermentation media of S. erythraea to examine the possible effects of magnetite nanoparticles on O2 transfer rate and final titer of fermentation product.

Methods

Materials

The erythromycin-producing strain Saccharopolyspora erythraea PTCC 1685 was obtained from Persian Type Culture Collection I-124, Iran. Soybean flour was supplied from Maxsoy Co., Iran. Chemical reagents and media were purchased from Merck or Sigma.

Synthesis of nanoparticles

Several procedures have been developed for synthesis of iron oxide nanoparticles [6],[7]. In this study, co-precipitation technique was used for synthesis of magnetite nanofluid, which is based on the simultaneous precipitation of Fe3+, Fe2+ ions in basic aqueous media [6]. Some advantages of this method include being straightforward, cheap, and environment-friendly, and producing a uniform size distribution of nanoparticles.

To prepare solution of MNPs, 23.5 g FeCl3.6H2O and 8.6 g FeCl2.4H2O were dissolved in 25 ml deionized water in an Erlenmeyer flask under Nitrogen sparging, 80°C and vigorous mechanical stirring. After 30 min, 45 ml of an aqueous solution of NH4OH was added to the mixture dropwise, after which the color of solution changes from light-brown to black, an indication of MNPs formation. The reaction was continued at 80°C under stirring and Nitrogen sparging conditions for 30 min to allow the substance completely crystalize. Afterwards the solution was cooled at room temperature [4],[8]-[10]. The process reaction follows the following formula:
FeC l 2 + 2 FeC l 3 + 8 N H 3 + 4 H 2 O 1200 rpm F e 3 O 4 + 8 N H 4 Cl

Due to their strong magnetic properties, the synthetic MNPs were aggregated near the magnet. MNPs were then washed with deionized water three time sat the end of process. Next, NPs were dried in oven at 80°C overnight to be characterized by XRD and TEM analysis [4].

Experimental determination of the volumetric mass transfer coefficient (KLa) by dynamic method

According to the Dynamic method [11] for determining mass transfer coefficient, first the concentration of the dissolved oxygen in the liquid phase in reduced by means of Nitrogen bubbling until the oxygen concentration falls to zero. Afterwards, by bubbling the air into the reaction container the concentration of dissolved oxygen is increased [11]-[13]. The KLa can then be calculated using the two-film theory. According to this theory, the rate of oxygen transfer from gas phase into liquid phase (at cell-free systems) is represented by:
dc dt = K L a C * - C L
(1)
where dc/dt is the accumulation rate of the oxygen in the liquid phase, KLa represents the lumped volumetric mass transfer coefficient, C* denotes the saturate concentration of the dissolved oxygen in the broth, and CL represents the dissolved oxygen concentration in the aqueous phase [14]. Integrating Equation 1 will result in Equation 2:
C L 1 C L 2 d C L C * - C L = t 1 t 2 K L a . dt
(2)
With CL1 = 0 at t1 = 0, the integrated form of Equation (2) can be represented as the Equation 3:
ln C * - C L 2 C * = - K L a . t 2
(3)

A plot of ln C * - C L C * vs . t will result in a straight line with slope of -KLa [12],[14].

Media and cultural method

Spores of S. erythraea were produced on slants of CSL agar medium after 14 days in incubator at 30°C [15]. Ingredients of the sporulation medium used in this study was (per liter): 10 g CSL, 10 g starch, 2.5 g CaCO3, 3 g (NH4)2SO4, 3 g NaCl, 20 g agar, 2 ml trace element (MgSO4.7H2O, FeSO4.7H2O, ZnSO4.7H2O, CuSO4.5H2O, CoCl2.6H2O, HCL 37%), pH 7 ± 0.1 [15]. A volume of 1 ml of spore suspension of strain was inoculated in a 1000 ml Erlenmeyer flask containing 100 ml of seeding medium and incubated at 30°C and 220 rpm for 48 hours on a shaker-incubator. The composition of seeding medium used in this study was (per liter): 30 g soybean meal, 10 g glucose, 10 g glycerol, 3.5 g (NH4)2SO4, 1 g (NH4)2HPO4, 5 g CaCO3, pH 7 ± 0 [15]. Based on strain's morphology (Figure 1), culture's pH and biomass, the best inoculum was selected to be inoculated (5% v/v) into fermentation flasks. Fermentations were carried out in 9 Erlenmeyer flasks of 1000 ml, containing 150 ml of fermentation media. The composition of fermentation media was (per liter): 30 g soybean meal, 40 g dextrin, 30 g starch, 2 g(NH4)2SO4, 0.15 g (NH4)2HPO4, 10 g CaCO3, 50 g rapeseed oil, pH 6.8. Two concentrations of MNPs (0.005, 0.02 v/v) were added to each fermentation flask. Flasks were then put in shaker-incubator at 33°C and 220 rpm for 11 days [15]-[17]. All experiments were performed in triplicate in six batches. Samples of 7 ml were taken on days 6, 8, and 10 for further analysis. Investigation of S. erythraea morphology indicated that the hyphae of the strain were lysed on day 12, hence, no further erythromycin production was occurred.
Figure 1

The mycelia of strain used as inoculum.

Erythromycin assay

Purification of erythromycin was carried out by centrifugation of the samples (4000 rpm, 20 min) followed by using magnet to separate the possibly remaining magnetite nanoparticles from the supernatant. The supernatant was then diluted with 0.2 M carbonate-bicarbonate buffer of pH9.6 and the total erythromycin was extracted with chloroform. The extracted erythromycin was then mixed with the bromophenol blue reagent. The absorbance of organic phase was measured at 415 nm by spectrophotometry [15]-[17].

Statistical analysis

T-test was used to examine the significance of the mean differences. KLa was calculated from regression analysis. P < 0.05 was considered as the statistical significance.

Results and discussion

Nanoparticles characterization

NPs' crystal structure

The crystal structure of the synthetized MNPs is characterized by X-ray powder diffraction (XRD) [9]. Figure 2 displays the structural properties of the MNPs as determined by XRD (Bruker axs D4, cu, step size 0.02). The XRD pattern shows the diffraction peaks at 2θ = 18.270°, 30.035°, 35.423° (strongest line), 43.053°, 53.392°, 56.944°, 62.516°, which correspond to the (111), (220), (311), (400), (422), (511), (440) reflections, respectively [9],[18]-[20].The XRD results show that the synthetized MNPs are well crystallized and the relative intensity of the diffraction peaks matches well with the reported XRD data for magnetite nanoparticles in the literature.
Figure 2

XRD pattern of synthetic nanoparticles.

NPs' size

Morphology and size of the prepared MNPs was determined by Transmission Electron Microscopy (TEM) (Figure 3) [10],[21]-[23]. A small amount of dried MNPs were dissolved in ethanol. The solution was then sonicated for better dispersion. A drop of the solution was then placed on a 200 mesh Copper grid and dried in the air. The sample was analyzed by TEM at 100 KV.
Figure 3

TEM image of magnetite nanoparticles.

Diameter of the MNPs was determined directly from the TEM image [24]. Figure 4 displays the histogram of NPs' size distribution (n = 300). A mean (SD) size of particles is 11.24 (3.5) nm was calculated.
Figure 4

The size distribution of magnetite nanoparticles.

Effect of nanoparticles on mass transfer coefficient

The changes in concentration of dissolved oxygen in deionized water at different concentrations of MNPs were measured during the absorption process, based on Dynamic method [11],[12], and compared with nanoparticle-free water, as the control. As shown in Figure 5, at all concentrations of MNPs, the amount of DO has increased and the time for achieving saturate concentration has decreased, when compared with the control. KLa was determined using the linearized curve of DO vs. time (see Methods). As shown in Figure 6, MNPs positively affects the mass transfer coefficient; KLa in water containing 0.02 v/v MNPs is 1.85 times higher than that in the control.
Figure 5

The dissolved oxygen at different concentrations of MNPs (each value in the figure is the mean of corresponding values from 3 repeated experiments).

Figure 6

The linearized curve of dissolved oxygen at different concentrations of MNPs (the slope of the curve represents-KLa).

Effect of MNPs on erythromycin titer

Magnetite MNPs with initial concentrations of zero (control medium), 0.005, 0.02 v/v were used in fermentation media of S. erythraea and their effect on erythromycin titer was examined. As shown in Figure 7, while the maximum concentration of erythromycin is 18.1 mg/lit in the control medium, in the medium with 0.02 v/v MNPs, a maximum titer of 32.86 mg/lit has obtained which is 2.25 times higher. Erythromycin final titer (day 10) in both 0.005 and 0.02 (v/v) media shows significant difference as compared with the control (P < 0.05). Figure 6 shows that this higher titer is due to the more prolonged production of erythromycin in MNP-containing medium compared to the control medium. It could be aurged that this higher titer is due to an extended viability of the microorganism as a result of higher OTR in the presence of MNPs.
Figure 7

Effect of different concentrations of nanoparticles on the production of erythromycin by S. erythraea (each value on the figure is the mean of corresponding values from 12 repeated experiments).

The chief objective of the present study was to explore the impact of MNPs on OTR and thereby titer of bioprocess product. MNPs are strong oxygen absorbent due to their increased surface area at nano scale. These nanoparticles have proven useful when used as recyclable oxygen carriers in aerobic fermentation [25]. A number of mechanisms proposed for the positive impact of MNPs on OTR include enhancing oxygen solubility in the fermentation medium, inducing microconvection in the surrounding fluid by Brownian motion [4], and enlarging the gas-liquid interfacial surface through being adsorbed on the air bubbles, preventing them from coalescence [26].

Results obtained in this study, which are in close agreement with the findings from previous researches [4],[25]-[27], add weight to the notion of MNPs being candidate members of O2-vectors that promote the oxygen transfer in stirred aerobic bioprocesses.

Composition of fermentation medium plays an important role in the titer of secondary metabolites and the cost of fermentation product [15]. Because the erythromycin producing bacterium, S. erythraea is an aerobic actinomycete, proper oxygenation is crucial to achieve a high yield of this substance. Our results clearly indicate that presence of MNPs remarkably enhance the erythromycin production by S. erythraea.

Possible toxicity of nanoparticles is a major concern, particularly when used in pharmaceutical bioprocesses [28],[29]. The fact that MNPs can be efficiently separated from fermentation medium, virtually eliminate the risk of possible toxic effects. On the other hand, the wide use of MNPs in environmental applications, including pollutant removal, toxicity mitigation, and water and waste treatment [30] indicates the safety of its use at limited doses. These advantages together with their positive impact on fermentation productivity as supported in this study, introduce use of them as a viable strategy for an improved pharmaceutical bioprocessing.

Conclusions

The metabolic rate and growth of microbial biocatalysts are controlled by oxygen; hence, for an improved yield of aerobic bioprocesses, there is a need for strategies enabling a high rate oxygen transfer, while maintain affordable energy consumption. Our results indicate that MNPs can improve the efficiency of oxygen transfer in the fermentation medium. Use of MNPs in the erythromycin fermentation culture enhanced erythromycin titer, presumably via promotion of microbial growth and viability. The straightforward and inexpensive synthetize of these biocompatible, non-toxic and non-volatile nanoparticles, together with their positive impact on oxygen transfer rate, introduce them as promising agents for achieving an enhanced productivity of the industrial bioprocesses.

Declarations

Acknowledgements

The authors wish to thank Dr. Meysam Mobasheri for participating in statistical analysis and revision of the manuscript.

Authors’ Affiliations

(1)
Department of Chemical Engineering, Science and Research Branch, Islamic Azad University(IAU)
(2)
Department of Pharmacology, School of Advanced Sciences and Technologies in Medicine, Tehran University of Medical Sciences
(3)
Department of Toxicology and Pharmacology, Islamic Azad University of Pharmaceutical Sciences Branch
(4)
Catalyst and Nanotechnology Division, Research Institute of Petroleum Industry

References

  1. Garcia-Ochoa F, Gomez E, Santos VE, Merchuk JC: Oxygen uptake rate in microbial processes. Biochem Eng J. 2010, 49: 289-307. 10.1016/j.bej.2010.01.011.View ArticleGoogle Scholar
  2. Fadavi A, Chisti Y: Gas-Liquid mass transfer in a novel forced circulation loop reactor. Chem Eng J. 2005, 112: 73-80. 10.1016/j.cej.2005.06.009.View ArticleGoogle Scholar
  3. Moutafchieva D, Popova D, Dimitrova M, Tchaoushev S: Experimental determination of the volumetric mass transfer coefficient. J Chem Technol Metallurgy. 2013, 48 (4): 351-356.Google Scholar
  4. Olle B, Bucak S, Holmes TC, Bromberg L, Hatton TA, Wang DIC: Enhancement of oxygen mass transfer using functionalized magnetic nanoparticles. Ind Eng Chem Res. 2006, 45: 4355-4363. 10.1021/ie051348b.View ArticleGoogle Scholar
  5. Nagy E, Feczko T, Koroknai B: Enhancement of oxygen mass transfer rate in the presence of nanosized particles. Chem Eng Sci. 2007, 62: 7391-7398. 10.1016/j.ces.2007.08.064.View ArticleGoogle Scholar
  6. Figuerola A, Di Corato R, Manna L, Pellegrino T: From iron oxide NPs towards advanced iron-based inorganic materials designed for biomedical applications. J Pharmacol Res. 2010, 62: 126-143. 10.1016/j.phrs.2009.12.012.View ArticleGoogle Scholar
  7. Lu AH, Salabas EL, Schuth F: Magnetic NPs: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007, 46: 1222-1244. 10.1002/anie.200602866.View ArticlePubMedGoogle Scholar
  8. Sun J, Zhou SH, Hou P, Yang Y, Weng J, Li X, Li M: Synthesis and characterization of biocompatible Fe3o4 Nanoparticles. J Biomed Mater Res. 2006, A: 333-341.Google Scholar
  9. Awwad AM, Salem NM: A green and facile approach for synthesis of magnetite NPs. Nanosci Nanotechnol. 2012, 2 (6): 208-213. 10.5923/j.nn.20120206.09.View ArticleGoogle Scholar
  10. Kafayati ME, Raheb J, TorabiAngazi M, Alizadeh SH, Bardania H: The Effect of magnetic Fe3O4 NPs on the growth of genetically manipulated bacterium, Pseudomonas aeruginosa. Iran J Biotechnol. 2013, 11 (1): 41-46. 10.5812/ijb.9302.View ArticleGoogle Scholar
  11. Garcia-Ochoa F, Gomez E: Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview. Biotechnol Adv. 2009, 27: 153-176. 10.1016/j.biotechadv.2008.10.006.View ArticlePubMedGoogle Scholar
  12. Juarez P, Orejas J: Oxygen transfer in a stirred reactor in laboratory scale. Lat Am Appl Res. 2001, 31: 433-439.Google Scholar
  13. Haribabu K, Sivasubramanian V: Determination of mass transfer coefficient in an inverse fluidized bed reactor using statistical and dynamic method for a non-Newtonian fluid. J Sci Ind Res. 2013, 72: 485-490.Google Scholar
  14. Nielsen DR, Daugulis AJ, McLellan PJ: A novel method of simulating oxygen mass transfer in two-phase partitioning bioreactors. J Biotech Bioeng. 2003, 83 (6): 735-742. 10.1002/bit.10721.View ArticleGoogle Scholar
  15. Hamedi J, Malekzadeh F, Saghafi-nia AE: Enhancing of erythromycin production by Saccharopolysporaeryhtraea with common and uncommon oils. J Microb Biotechnol. 2004, 31: 447-456. 10.1007/s10295-004-0166-1.View ArticleGoogle Scholar
  16. Rostamza M, Noohi A, Hamedi J: Enhancement in production of erythromycin by Saccharopolyspora erythraea by the Use of suitable industrial seeding-media. Daru J Pharm Sci. 2008, 1: 13-17.Google Scholar
  17. Hamedi J, Khodagholi F, Hassani-Nasab A: Increased erythromycin production by alginate as a medium ingredient or immobilization support in cultures of Saccharopolyspora erythraea. Biotechnol Lett. 2005, 27: 661-664. 10.1007/s10529-005-4476-9.View ArticlePubMedGoogle Scholar
  18. Wang B, Wei Q, Qu SH: Synthesis and characterization of uniform and crystalline magnetite nanoparticles via oxidation-precipitation and modified co-precipitation method. Int J Electrochem Sci. 2013, 8: 3786-3793.Google Scholar
  19. Shaker S, Zafarian SH, Chakra SH, Rao KV: Preparation and characterization of magnetite nanoparticles by Sol-Gel method for water treatment. Int J Inn Res Sci Eng Technol. 2013, 2 (7): 2969-2973.Google Scholar
  20. Bahrampour F, Raheb J, Rabiei Z: Alteration in protein profile of Pseudomonas aeruginosa (PTSOX4) coated with magnetic nanoparticles. J Nanostructure Chem. 2013, 3 (58): 1-8.Google Scholar
  21. Wang R, Zuo SH, Zhu W, Zhang J, Fang J: Rapid synthesis of Aqueous-Phase magnetite nanoparticles by atmospheric pressure Non-Thermal microplasma and their application in magnetic resonance imaging. Plasma Process Polym. 2014, 11 (5): 448-454. 10.1002/ppap.201300168.View ArticleGoogle Scholar
  22. Giraldo L, Moreno-Pirajan JC: Synthesis of magnetite nanoparticles and exploring their application in the removal of Pt2+ andAu3 + ions from aqueous solutions. Eur Chem Bull. 2013, 7: 445-452.Google Scholar
  23. Mahmed N, Eczko OH, Soderberg O, Hannula SP: Room temperature synthesis of magnetite nanoparticles by a simple reverse Co-Precipitation method. Mater Sci Eng. 2011, 18: 1-4.Google Scholar
  24. Ghalamboran MR, Ramsden J, Ansari F: Growth rate enhancement of Bradyrhizobium japanicum due to magnetite nanoparticles. J Bionanosci. 2009, 3: 1-6. 10.1166/jbns.2009.1021.View ArticleGoogle Scholar
  25. Bromberg LE, Hatton TA, Wang IC, Yin J, Olle B: Bioprocesses enhanced by magnetic nanoparticles, United States patent. 2006, US0040388A1:1-23.Google Scholar
  26. Dobre T, Ohreac BS, Parvulescu OC, Danciu TD: Effect of solid carriers on oxygen mass transfer in a stirred tank bioreactor. REVCHIM (Bucharest). 2014, 65 (4): 489-496.Google Scholar
  27. Saeednia L, Hashemi Pour H, Afzali D: Effect of nanoparticles on gas-liquid mass transfer coefficient. Iran Chem Eng J. 2013, 12 (66): 50-57.Google Scholar
  28. Mostafalou S, Mohammadi H, Ramazani A, Abdollahi M: Different biokinetics of nanomedicines linking to their toxicity; an overview.Daru J Pharm Sci 2013, 21:14.,View ArticleGoogle Scholar
  29. Mogharabi M, Abdollahi M, Faramarzi M: Toxicity of nanomaterials; an undermined issue.Daru J Pharm Sci 2014, 22:59.,View ArticleGoogle Scholar
  30. Tang SCN, Lo IMC: Magnetic nanoparticles: essential factors for sustainable environmental applications. J Water Res. 2013, 47: 2613-2632. 10.1016/j.watres.2013.02.039.View ArticleGoogle Scholar

Copyright

© Labbeiki et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement